Popular Articles

The Medical Consequences Of Police Use Of Force During Restraint: Two Studies
Dr. Jared Strote at the University of Washington Medical Center led a group that examined the medical records of nearly 900 patients subdued by the Seattle Police Department with a Taser over a six-year period. Less than one percent required hospital admission for an injury related to the restraint incident. No deaths occurred, even when patients exhibited signs of excited delirium.

Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval To Proceed With Phase 3 Development Of OnaltaTM
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced that the European Medicines Agency (EMEA) has approved its Phase 3 protocol for Onalta (Yttrium-90 edotreotide). Onalta is the Company"s lead radiotherapeutic product candidate under development for the treatment of metastatic carcinoid and pancreatic neuroendocrine tumors in patients whose symptoms are not controlled by conventional therapy. The compound has shown the potential to selectively deliver lethal radiation to cancer cells. The proposed Phase 3 trial will confirm that administration of Onalta results in stabilization, regression or complete remission of the carcinoid tumor, and improves carcinoid-related symptoms when compared to a high-dose regimen of the current standard therapy for this disease, Sandostatin®. With EMEA"s approval of its proposed Phase 3 protocol in hand, Molecular Insight can proceed with the final clinical trial that will position Onalta for marketing authorization in the EU.
News of the day
At American Diabetes Association Meeting, 2 Preclinical Abstracts Published By Versartis
Versartis, Inc., a new company developing novel biologics with enhanced properties for patients with metabolic diseases, published abstracts for preclinical data on its two product candidates, VRS-859 (exenatide-rPEG) and VRS-808 (glucagon-rPEG), at the American Diabetes Association Scientific Sessions annual meeting in New Orleans.
Medical Devices

Private Health Insurance Coverage At 50-Year-Low, According To CDC

The percentage of Americans with private health insurance is at its lowest level in 50 years, the Centers for Disease Control and Prevention said Wednesday, according to The Associated Press. "About 65 percent of non-elderly Americans had private insurance in 2008, down from 67 percent the year before, according to preliminary data released Wednesday by the (CDC)." "In the 1970s and early 1980s, nearly 80 percent of Americans had private coverage, according to CDC officials. "Some experts blamed the faltering economy and corporate decisions to raise health insurance premiums - or do away with employee coverage - as the main drivers of the recent data. They say coverage statistics for 2009 may look even worse." Public coverage of adults is rising in some states because of expanding Medicaid eligibility. The CDC estimates - through a survey - that 44 million Americans were uninsured last year, about the same for other recent years. "The CDC also reported on insurance coverage in the 20 largest states, and found the percent of uninsured people ranged from 3 percent in Massachusetts to 23 percent in Texas. Lack of health insurance was greatest in the South and West" (Stobbe, 7/1). All Headline News reports: "The report shows that the number of uninsured children has decreased significantly - almost 14 percent to 8.9 percent - from 1997 to 2008. More than 34 percent of the nation"s children have public health coverage. The CDC also released a second report on health insurance that examined coverage trends from 1959 to 2007. Among its chief findings was that the number of people under 65 with no coverage has increased by more than 20 percent since its lowest point in 1978" (Goodhue, 7/2). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):